Implantable continuous-flow right ventricular assist device: lessons learned in the development of a cleveland clinic device.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 22459544.
- Also identified by DOI 10.1016/j.athoracsur.2012.02.026 and PMC identifier 3447008.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Although the need for right ventricular assist device (RVAD) support for right ventricular failure after the implantation of a continuous-flow left ventricular assist device has decreased, right ventricular failure still occurs in as many as 44% of patients after continuous-flow left ventricular assist device insertion. Cleveland Clinic's DexAide continuous-flow RVAD was implanted in 34 calves during the course of its development. This review discusses lessons learned in the design and development of an implantable continuous-flow RVAD that are drawn from the results of these in vivo studies, our clinical experience with RVAD support, and a review of previously published reports on clinical RVAD use.
Medical subject headings
- Equipment Design
- Equipment Failure
- Heart-Assist Devices
- Ventricular Dysfunction, Right